Cannabidiol, a non‐psychotropic component of cannabis, attenuates vomiting and nausea‐like behaviour via indirect agonism of 5‐HT1A somatodendritic autoreceptors in the dorsal raphe nucleus

Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922

The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin

Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047

Guide to receptors and channels (GRAC), 5th edition

Alexander, S., Mathie, A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_1.x · Cited by 1,947

The taste reactivity test. I. Mimetic responses to gustatory stimuli in neurologically normal rats

Grill, H. J., & Norgren, R. (1978) · Brain Research · doi:10.1016/0006-8993(78)90568-1 · Cited by 1,220

G Protein-Coupled Receptor Allosterism and Complexing

Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 934

Agonistic properties of cannabidiol at 5-HT1a receptors

Russo, E. B., Burnett, A., Hall, B., & Parker, K. K. (2005) · Neurochemical Research · doi:10.1007/s11064-005-6978-1 · Cited by 878

Cannabidiol and (−)Δ 9 -tetrahydrocannabinol are neuroprotective antioxidants

Hampson, A. J., Grimaldi, M., Axelrod, J., & Wink, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.14.8268 · Cited by 850

Cannabidiol displays unexpectedly high potency as an antagonist of CB 1 and CB 2 receptor agonists in vitro

Thomas, A., Baillie, G. L., Phillips, A. M., Razdan, R. K., Ross, R. A., & Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707133 · Cited by 763

Evidence for a viscerotopic sensory representation in the cortex and thalamus in the rat

Cechetto, D. F., & Saper, C. B. (1987) · Journal of Comparative Neurology · doi:10.1002/cne.902620104 · Cited by 703

The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis

Malfait, A. M., Gallily, R., Sumariwalla, P. F., Malik, A. S., Andreakos, E., Mechoulam, R., & Feldmann, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160105897 · Cited by 669

Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research

Caprioglio, D., Amin, H. I. M., Taglialatela‐Scafati, O., Muñóz, E., & Appendino, G. (2022) · Biomolecules · doi:10.3390/biom12081084 · Cited by 37

Drug–Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics

Buchtová, T., Lukáč, D., Škrott, Z., Chromá, K., Bártek, J., & Mistrík, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032885 · Cited by 38

Fetal cannabidiol (CBD) exposure alters thermal pain sensitivity, problem-solving, and prefrontal cortex excitability

Swenson, K. S., Wulschner, L. E. G., Hoelscher, V. M., Folts, L. M., Korth, K. M., Oh, W. C., & Bates, E. A. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02130-y · Cited by 38

Synaptic changes induced by cannabinoid drugs and cannabis use disorder

Augustin, S. M., & Lovinger, D. M. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105670 · Cited by 38

Assessment of clinical outcomes of medicinal cannabis therapy for depression: analysis from the UK Medical Cannabis Registry

Mangoo, S., Erridge, S., Holvey, C., Coomber, R., Barros, D. A. R., Bhoskar, U., Mwimba, G., Praveen, K., Symeon, C., Sachdeva-Mohan, S., et al. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2161894 · Cited by 35

Evaluation of the potential of the phytocannabinoids, cannabidivarin ( CBDV ) and Δ9‐tetrahydrocannabivarin ( THCV ), to produce CB1 receptor inverse agonism symptoms of nausea in rats

Rock, E. M., Sticht, M. A., Duncan, M., Stott, C. G., & Parker, L. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12322 · Cited by 35

Roles of the Cannabinoid System in the Basal Ganglia in Parkinson’s Disease

Wang, M., Liu, H., & Ma, Z. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.832854 · Cited by 36

Prenatal tetrahydrocannabinol and cannabidiol exposure produce sex-specific pathophysiological phenotypes in the adolescent prefrontal cortex and hippocampus

DeVuono, M. V., Nashed, M. G., Sarikahya, M. H., Kocsis, A., Lee, K., Vanin, S., Hudson, R., Lonnee, E. P., Rushlow, W. J., Hardy, D. B., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106588 · Cited by 34

Neuroprotective effect of chronic administration of cannabidiol during the abstinence period on methamphetamine-induced impairment of recognition memory in the rats

Razavi, Y., Shabani, R., Mehdizadeh, M., & Haghparast, A. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000544 · Cited by 34

Cannabidiol Interacts Antagonistically with Cisplatin and Additively with Mitoxantrone in Various Melanoma Cell Lines—An Isobolographic Analysis

Marzęda, P., Wróblewska-Łuczka, P., Drozd, M., Florek-Łuszczki, M., Załuska-Ogryzek, K., & Łuszczki, J. J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126752 · Cited by 34

An update of nano-based drug delivery systems for cannabinoids: Biopharmaceutical aspects & therapeutic applications

Rebelatto, E. R. L., Rauber, G. S., & Caon, T. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122727 · Cited by 34

Conversion of cannabidiol (CBD) to Δ9-tetrahydrocannabinol (Δ9-THC) during protein precipitations prior to plasma samples analysis by chromatography – Troubles with reliable CBD quantitation when acidic precipitation agents are applied

Dybowski, M. P., Dawidowicz, A. L., Typek, R., & Rombel, M. (2020) · Talanta · doi:10.1016/j.talanta.2020.121390 · Cited by 33

Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications

Tambe, S. M., Mali, S. N., Amin, P. D., & de Oliveira, M. S. (2023) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2023.03.004 · Cited by 34

Cannabinoid Hyperemesis Syndrome: Case Report of a Paradoxical Reaction with Heavy Marijuana Use

Cox, B. R., Chhabra, A., Adler, M., Simmons, J., & Randlett, D. (2012) · Case Reports in Medicine · doi:10.1155/2012/757696 · Cited by 33

Neuroprotective Effects of Cannabidiol but Not Δ9-Tetrahydrocannabinol in Rat Hippocampal Slices Exposed to Oxygen-Glucose Deprivation: Studies with Cannabis Extracts and Selected Cannabinoids

Landucci, E., Mazzantini, C., Lana, D., Davolio, P. L., Giovannini, M. G., & Pellegrini-Giampietro, D. E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189773 · Cited by 31

Endocannabinoid-serotonin systems interaction in health and disease

Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 31

Phytochemical and biological research of Papaver pharmaceutical resources

Hao, D., Gu, X.-J., & Xiao, P. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100085-4.00006-2 · Cited by 30

Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping

Rock, E. M., Limebeer, C. L., & Parker, L. A. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4080-1 · Cited by 29

Cannabinoids and Cancer Chemotherapy-Associated Adverse Effects

Ward, S. J., Lichtman, A. H., Piomelli, D., & Parker, L. A. (2021) · JNCI Monographs · doi:10.1093/jncimonographs/lgab007 · Cited by 29

Cannabinoid Regulation of Acute and Anticipatory Nausea

Rock, E. M., Sticht, M. A., Limebeer, C. L., & Parker, L. A. (2016) · Cannabis and Cannabinoid Research · doi:10.1089/can.2016.0006 · Cited by 29

CBD and the 5-HT1A receptor: A medicinal and pharmacological review

Alexander, C., Jeon, J., Nickerson, K., Hassler, S. N., & Vasefi, M. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.116742 · Cited by 28

Cannabidiol and the Remainder of the Plant Extract Modulate the Effects of Δ9-Tetrahydrocannabinol on Fear Memory Reconsolidation

Murkar, A., Kent, P., Cayer, C., James, J., Durst, T., & Merali, Z. (2019) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2019.00174 · Cited by 29

Cannabinoids and neuroinflammation: Therapeutic implications

Leonard, B. E., & Arıcıoğlu, F. (2023) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2023.100463 · Cited by 28

Cannabigerol modulates α2-adrenoceptor and 5-HT1A receptor-mediated electrophysiological effects on dorsal raphe nucleus and locus coeruleus neurons and anxiety behavior in rat

Mendiguren, A., Aostri, E., Rodilla, I., Pujana, I., Noskova, E., & Pineda, J. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1183019 · Cited by 27

Cannabidiol Attenuates MK-801-Induced Cognitive Symptoms of Schizophrenia in the Passive Avoidance Test in Mice

Kruk-Słomka, M., & Biała, G. (2021) · Molecules · doi:10.3390/molecules26195977 · Cited by 27

Cannabidiol attenuates fear memory expression in female rats via hippocampal 5-HT1A but not CB1 or CB2 receptors

Franzen, J. M., Werle, I., Vanz, F., de Oliveira, B. B., Nascimento, L. M. M., Guimarães, F. S., & Bertoglio, L. J. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109316 · Cited by 27

Assessment of clinical outcomes in patients with post-traumatic stress disorder: analysis from the UK Medical Cannabis Registry

Pillai, M., Erridge, S., Bapir, L., Nicholas, M., Dalavaye, N., Holvey, C., Coomber, R., Barros, D. A. R., Bhoskar, U., Mwimba, G., et al. (2022) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2022.2155139 · Cited by 28

The Anxiolytic Effects of Cannabidiol (CBD)

Zuardi, A. W., Crippa, J. A. S., Hallak, J. E. C., Campos, A. C., & Guimarães, F. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-800756-3.00097-1 · Cited by 29

Research and Clinical Practice Involving the Use of Cannabis Products, with Emphasis on Cannabidiol: A Narrative Review

Simei, J. L. Q., Souza, J. D. R., Pedrazzi, J. F. C., Guimarães, F. S., Campos, A. C., Zuardi, A. W., Hallak, J. E. C., & Crippa, J. A. S. (2024) · Pharmaceuticals · doi:10.3390/ph17121644 · Cited by 27

Cannabidiol on 5‐FU‐induced oral mucositis in mice

Cuba, L. D. F., Salum, F. G., Guimarães, F. S., Cherubini, K., Borghetti, R. L., & de Figueiredo, M. A. Z. (2020) · Oral Diseases · doi:10.1111/odi.13413 · Cited by 26

HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid

Haj, C. G., Sumariwalla, P. F., Hanuš, L., Kogan, N. M., Yektin, Z., Mechoulam, R., Feldmann, M., & Gallily, R. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.226100 · Cited by 26

CBGA ameliorates inflammation and fibrosis in nephropathy

Suzuki, S., Fleig, A., & Penner, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-33507-2 · Cited by 25

Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders

Sampaio, M. D. F. D. S., de Paiva, Y. B., Sampaio, T. B., Pereira, M. G., & Coimbra, N. C. (2024) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13997 · Cited by 28

Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew).

Rock, E. M., & Parker, L. A. (2015) · Behavioral Neuroscience · doi:10.1037/bne0000057 · Cited by 25

Effects of daily Δ9-Tetrahydrocannabinol (THC) alone or combined with cannabidiol (CBD) on cognition-based behavior and activity in adolescent nonhuman primates

Withey, S. L., Kangas, B. D., Charles, S., Gumbert, A. B., Eisold, J. E., George, S. R., Bergman, J., & Madras, B. K. (2021) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2021.108629 · Cited by 24

Brain endocannabinoid signaling exhibits remarkable complexity

Gorzkiewicz, A., & Szemraj, J. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.012 · Cited by 26

Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

Rock, E. M., Sullivan, M. T., Collins, S. A., Goodman, H., Limebeer, C. L., Mechoulam, R., & Parker, L. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05559-z · Cited by 24

Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment

Schanknecht, E., Bachari, A., Nassar, N., Piva, T. J., & Mantri, N. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010859 · Cited by 26

Ondansetron interferes with unconditioned lying-on belly and acquisition of conditioned gaping induced by LiCl as models of nausea-induced behaviors in rats

Tuerke, K. J., Winters, B. D., & Parker, L. A. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.10.017 · Cited by 24

The Pharmacological Effects of Plant-Derived versus Synthetic Cannabidiol in Human Cell Lines

Maguire, R., Wilkinson, D. J., England, T. J., & O’Sullivan, S. E. (2021) · Medical Cannabis and Cannabinoids · doi:10.1159/000517120 · Cited by 24

Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry

Bellocchio, L., Patano, A., Inchingolo, A. D., Inchingolo, F., Dipalma, G., Isacco, C. G., de Ruvo, E., Rapone, B., Mancini, A., Lorusso, F., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119693 · Cited by 29

Cannabidiol and its Potential Evidence-Based Psychiatric Benefits – A Critical Review

Dammann, I., Rohleder, C., & Leweke, F. M. (2024) · Pharmacopsychiatry · doi:10.1055/a-2228-6118 · Cited by 24

Cannabidiol activation of vagal afferent neurons requires TRPA1

Kowalski, C. W., Ragozzino, F. J., Lindberg, J. E. M., Peterson, B., Lugo, J. M., McLaughlin, R. J., & Peters, J. H. (2020) · Journal of Neurophysiology · doi:10.1152/jn.00128.2020 · Cited by 23

Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models

Rock, E. M., Connolly, C., Limebeer, C. L., & Parker, L. A. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4378-7 · Cited by 22

Considerations for Cannabinoids in Perioperative Care by Anesthesiologists

Laudański, K., & Wain, J. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11030558 · Cited by 22

Cannabinoid modulation of mother-infant interaction: is it just about milk?

Manduca, A., Campolongo, P., & Trezza, V. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2012-0074 · Cited by 22

Adjunctive Management of Opioid Withdrawal with the Nonopioid Medication Cannabidiol

Kudrich, C., Hurd, Y. L., Salsitz, E. A., & Wang, A. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0089 · Cited by 21

Beyond the hype: a comprehensive exploration of CBD’s biological impacts and mechanisms of action

Swenson, K. S. (2025) · Journal of Cannabis Research · doi:10.1186/s42238-025-00274-y · Cited by 20

The NLRP3 Inflammasome in Stress Response: Another Target for the Promiscuous Cannabidiol

dos Santos, A. H., Vila-Verde, C., Guimarães, F. S., Joca, S. R. L., & Lisboa, S. F. D. S. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220411101217 · Cited by 20

Endocannabinoid Mechanisms Influencing Nausea

Sticht, M. A., Rock, E. M., Limebeer, C. L., & Parker, L. A. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.09.001 · Cited by 20

Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence

Zavala‐Tecuapetla, C., Luna‐Munguía, H., López‐Meraz, M. L., & Cuéllar‐Herrera, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416181 · Cited by 19

Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review

Ostadhadi, S., Rahmatollahi, M., Dehpour, A. R., & Rahimian, R. (2014) · Phytotherapy Research · doi:10.1002/ptr.5265 · Cited by 19

Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys

McMahon, L. R. (2016) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2016.05.016 · Cited by 19

Attenuation of Novelty-Induced Hyperactivity of Gria1-/- Mice by Cannabidiol and Hippocampal Inhibitory Chemogenetics

Aitta‐aho, T., Maksimovic, M., Dahl, K., Sprengel, R., & Korpi, E. R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00309 · Cited by 19

Effect of combined doses of Δ9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

Rock, E. M., Sullivan, M. T., Pravato, S., Pratt, M., Limebeer, C. L., & Parker, L. A. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05428-4 · Cited by 19

Targeting Nrf2 Signaling Pathway in Cancer Prevention and Treatment: The Role of Cannabis Compounds

Rybarczyk, A., Majchrzak‐Celińska, A., & Krajka‐Kuźniak, V. (2023) · Antioxidants · doi:10.3390/antiox12122052 · Cited by 18

Anticipatory nausea in animal models: a review of potential novel therapeutic treatments

Rock, E. M., Limebeer, C. L., & Parker, L. A. (2014) · Experimental Brain Research · doi:10.1007/s00221-014-3942-9 · Cited by 18

Cannabinoid drugs against chemotherapy-induced adverse effects: focus on nausea/vomiting, peripheral neuropathy and chemofog in animal models

Bagüés, A., López‐Tofiño, Y., Llorente‐Berzal, A., & Abalo, R. (2022) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000667 · Cited by 18

Allosteric Modulators of Serotonin Receptors: A Medicinal Chemistry Survey

Brunetti, L., Francavilla, F., Leopoldo, M., & Lacivita, E. (2024) · Pharmaceuticals · doi:10.3390/ph17060695 · Cited by 16

Cannabidiol impairs fear memory reconsolidation in female rats through dorsal hippocampus CB1 but not CB2 receptor interaction

Franzen, J. M., Vanz, F., Werle, I., Guimarães, F. S., & Bertoglio, L. J. (2022) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2022.08.002 · Cited by 18

From bench to bedside: the application of cannabidiol in glioma

Feng, S., Pan, Y., Lu, P., Li, N., Zhu, W., & Hao, Z. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05477-0 · Cited by 16

Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid

Rock, E. M., & Parker, L. A. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.012 · Cited by 16

Cannabis Vapor Exposure Alters Neural Circuit Oscillatory Activity in a Neurodevelopmental Model of Schizophrenia: Exploring the Differential Impact of Cannabis Constituents

Jenkins, B. W., Buckhalter, S., Perreault, M. L., & Khokhar, J. Y. (2021) · Schizophrenia Bulletin Open · doi:10.1093/schizbullopen/sgab052 · Cited by 15

Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders

Kumar, U. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms26010152 · Cited by 15

Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain

Xantus, G. Z., Závori, L., Matheson, C., Gyarmathy, V. A., Fazekas, L. M., & Kanizsai, P. (2021) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2021.1917379 · Cited by 14

Cannabidiol Interferes with Establishment of Δ 9 -Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism

DeVuono, M. V., Caprara, O. L., Petrie, G. N., Limebeer, C. L., Rock, E. M., Hill, M. N., & Parker, L. A. (2020) · Cannabis and Cannabinoid Research · doi:10.1089/can.2020.0083 · Cited by 14

Conditioned gaping produced by high dose Δ9-tetrahydracannabinol: Dysregulation of the hypothalamic endocannabinoid system

DeVuono, M. V., Hrelja, K. M., Sabaziotis, L., Rajna, A., Rock, E. M., Limebeer, C. L., Mutch, D. M., & Parker, L. A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.08.039 · Cited by 14

Role of the stress response and the endocannabinoid system in Δ9-tetrahydrocannabinol (THC)-induced nausea

DeVuono, M. V., Caprara, O. L., Sullivan, M. T., Bath, A., Petrie, G. N., Limebeer, C. L., Rock, E. M., Hill, M. N., & Parker, L. A. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05529-5 · Cited by 15

Different responses of repetitive behaviours in juvenile and young adult mice to Δ9‐tetrahydrocannabinol and cannabidiol may affect decision making for Tourette syndrome

Gorberg, V., McCaffery, P. J. A., & Anavi‐Goffer, S. (2020) · British Journal of Pharmacology · doi:10.1111/bph.15302 · Cited by 14

Cannabinoid 2 (CB 2 ) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats

Rock, E. M., Boulet, N., Limebeer, C. L., Mechoulam, R., & Parker, L. A. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.06.001 · Cited by 14

Functional characterization of cannabidiol effect on the serotonergic neurons of the dorsal raphe nucleus in rat brain slices

Mendiguren, A., Aostri, E., Alberdi, E. M., Pérez‐Samartín, A., & Pineda, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.956886 · Cited by 13

Cannabidiol: Science, Marketing, and Legal Perspectives

Wiley, J. L., Gourdet, C., & Thomas, B. F. (2020) · doi:10.3768/rtipress.2020.op.0065.2004 · Cited by 13

The Impact of Cannabidiol on the Induction of Isoflurane Anesthesia and Recovery in Wistar Rats

Uršič, M., Babič, A., Vake, T., & Snoj, T. (2021) · Cannabis and Cannabinoid Research · doi:10.1089/can.2021.0014 · Cited by 12

Phytocannabinoids as Chemotherapy Adjuncts—A Review for Users

Nahler, G. (2024) · Onco · doi:10.3390/onco4040021 · Cited by 12

Phytochemical and biological research of Cannabis pharmaceutical resources

Hao, D., Gu, X.-J., & Xiao, P. G. (2015) · Elsevier eBooks · doi:10.1016/b978-0-08-100085-4.00011-6 · Cited by 12

Whole proteome mapping of compound-protein interactions

Chirasani, V. R., Wang, J., Sha, C. M., Raup‐Konsavage, W. M., Vrana, K. E., & Dokholyan, N. V. (2022) · Current Research in Chemical Biology · doi:10.1016/j.crchbi.2022.100035 · Cited by 11

Cannabidiol and Intestinal Motility: a Systematic Review

Story, G., Briere, C., McClements, D. J., & Sela, D. A. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.101972 · Cited by 11

Neuromolecular Mechanisms of Cannabis Action

Adel, Y., & Alexander, S. P. H. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_2 · Cited by 11

Clinical Approaches to Cannabis

Slawek, D. E., Curtis, S. A., Arnsten, J. H., & Cunningham, C. O. (2021) · Medical Clinics of North America · doi:10.1016/j.mcna.2021.08.004 · Cited by 11

Cannabidiol and 5-HT1A Receptors

Fogaça, M. V., Campos, A. C., & Guimarães, F. S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00070-5 · Cited by 11

Modulation of Noradrenergic and Serotonergic Systems by Cannabinoids: Electrophysiological, Neurochemical and Behavioral Evidence

Mendiguren, A., Aostri, E., & Pineda, J. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_8 · Cited by 10

Cannabinoid hyperemesis syndrome: A review

Jiménez‐Castillo, R. A., Arumugam, S., Remes-Troche, J. M., & Venkatesan, T. (2025) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2025.02.002 · Cited by 9

Medicinal Cannabis: an overview for health-care providers

Wallach, J. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-820007-0.00005-2 · Cited by 9

Emerging medications and pharmacological treatment approaches for substance use disorders

Raymond, J. S., Athanasopoulos, A. G., Badolato, C. J., Doolan, T. M., Scicluna, R. L., Everett, N. A., Bowen, M. T., & James, M. H. (2024) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2024.173952 · Cited by 9

Assessing Dose- and Sex-Dependent Antinociceptive Effects of Cannabidiol and Amitriptyline, Alone and in Combination, and Exploring Mechanism of Action Involving Serotonin 1A Receptors

Barnes, R. C., Banjara, S., McHann, M. C., Almodóvar, S., Henderson, A. N., Morgan, D. J., Castro‐Piedras, I., & Guindon, J. (2023) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.123.001855 · Cited by 8

Cannabidiol (CBD) modulates the transcriptional profile of ethanol-exposed human dermal fibroblast cells

Gurgul, A., Żurowski, J., Szmatoła, T., Kucharski, M., Sawicki, S., Semik‐Gurgul, E., & Oclon, E. A. (2024) · Journal of Applied Genetics · doi:10.1007/s13353-024-00915-7 · Cited by 7

Synthetic and Natural Derivatives of Cannabidiol

Morales, P., & Jagerovic, N. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-61663-2_2 · Cited by 7

Cannabidiol bei Tumorerkrankungen

Likar, R., Köstenberger, M., & Nahler, G. (2020) · Der Schmerz · doi:10.1007/s00482-019-00438-9 · Cited by 7

Formation of trifluoroacetic artefacts in gas chromatograph injector during Cannabidiol analysis

Hołowiński, P., Typek, R., Dawidowicz, A. L., Rombel, M., & Dybowski, M. P. (2022) · Journal of Chromatography A · doi:10.1016/j.chroma.2022.463020 · Cited by 7

Therapeutic potential of cannabidiol in depression

Guldager, M. B., Filho, A. M. C., Biojone, C., & Joca, S. R. L. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.06.001 · Cited by 6

The Therapeutic Potential of Cannabidiol in the Management of Temporomandibular Disorders and Orofacial Pain

Walczyńska-Dragon, K., Kurek-Górecka, A. M., Fiegler-Rudol, J., Nitecka-Buchta, A., & Baron, S. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17030328 · Cited by 6

The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration

Kajero, J. A., Seedat, S., OHAERI, J. U., Akindele, A. J., & Aina, O. O. (2022) · Acta Neuropsychiatrica · doi:10.1017/neu.2022.29 · Cited by 6

Cannabis: Drug of Abuse and Therapeutic Agent, Two Sides of the Same Coin

Canseco-Alba, A., & Rodrı́guez–Manzo, G. (2023) · Revista de investigaci�n Cl�nica · doi:10.24875/ric.23000112 · Cited by 6

A comprehensive molecular analysis of cannabidiol: From solid state to antioxidant potential

Aguiar, A. S. N., Veloso, C., Tejota, Y. B. R., Martins, J. L. R., Fajemiroye, J. O., Borges, L. L., Camargo, A. J., Dias, L. D., & Napolitano, H. B. (2024) · Computational and Theoretical Chemistry · doi:10.1016/j.comptc.2024.114890 · Cited by 6

DSP‐1053, a novel serotonin reuptake inhibitor with 5‐HT1Apartial agonistic activity, displays fast antidepressant effect with minimal undesirable effects in juvenile rats

KATO, T., Matsumoto, Y., Yamamoto, M., Matsumoto, K., Baba, S., Nakamichi, K., Matsuda, H., Nishimuta, H., & Yabuuchi, K. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.142 · Cited by 7

Therapeutic Effects of Cannabidiol on Methamphetamine Abuse: A Review of Preclinical Study.

Razavi, Y., Keyhanfar, F., Shabani, R., Haghparast, A., & Mehdizadeh, M. (2021) · PubMed Central · doi:10.22037/ijpr.2021.114918.15106 · Cited by 6

Can cannabidiol have an analgesic effect?

Kulesza, B., Mazurek, M., & Kurzepa, J. (2023) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12947 · Cited by 6

Role of integrating cannabinoids and the endocannabinoid system in neonatal hypoxic-ischaemic encephalopathy

Xiao, J., Zhou, Y., Sun, L., & Wang, H. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1152167 · Cited by 6

Evaluation of Sex Differences in the Potential of Δ 9 -Tetrahydrocannabinol, Cannabidiol, Cannabidiolic Acid, and Oleoyl Alanine to Reduce Nausea-Induced Conditioned Gaping Reactions in Sprague-Dawley Rats

Rock, E. M., Limebeer, C. L., Smoum, R., Mechoulam, R., & Parker, L. A. (2022) · Cannabis and Cannabinoid Research · doi:10.1089/can.2022.0158 · Cited by 5

Role of interplay between endocannabinoids and neuropeptides in pathogenesis and therapy of depressive and anxiety disorders

Gołyszny, M. J., Dragon, J., & Obuchowicz, E. (2025) · Neuropeptides · doi:10.1016/j.npep.2025.102564 · Cited by 4

Cannabidiol Indirectly Activates 5-HT1A Somatodendritic Autoreceptors to Attenuate Vomiting and Nausea

Rock, E. M. (2011) · The Atrium (University of Guelph)

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea‐induced behaviour in rats by enhancing 5‐HT1A receptor activation

Bolognini, D., Rock, E., Cluny, N., Cascio, M., Limebeer, C., Duncan, M., Stott, C., Javid, F., Parker, L., & Pertwee, R. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12043 · Cited by 151

Cannabidiolic acid enhances 5-HT1A receptor activation and prevents vomiting in Suncus murinus and nausea-like behaviour in rats with greater potency and selectivity than cannabidiol

Bolognini, D., Rock, E. M., Cluny, N. L., Cascio, M. G., Limebeer, C. L., Duncan, M., Stott, C. G., Javid, F. A., Parker, L. A., & Pertwee, R. G. (2013) · University of Huddersfield Repository (University of Huddersfield)

Regulation of nausea and vomiting by cannabinoids

Parker, L. A., Rock, E. M., & Limebeer, C. L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01176.x · Cited by 267

Electrophysiological study of the effect of cannabidiol on the dorsal raphe nucleus serotonergic neurons

Aostri, E., Pineda, J., & Mendiguren, A. (2017) · MOL2NET International Conference on Multidisciplinary Sciences (MOL2NET) · doi:10.3390/mol2net-03-05083